Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS2356062 A
Publication typeGrant
Publication dateAug 15, 1944
Filing dateFeb 3, 1942
Priority dateFeb 3, 1942
Publication numberUS 2356062 A, US 2356062A, US-A-2356062, US2356062 A, US2356062A
InventorsCharles C Johnson
Original AssigneeLatimer Lab Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Therapeutic composition
US 2356062 A
Abstract  available in
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Patented Aug. 15, 1944 THERAPEUTIC comosrrron Charles 0. JohnsomNew York, N. Y., assignor to Inc., New York, N. -Y., a

Latimer Laboratory,

York

No Drawing. Application February 3, 1942,

I corporation of New Serial No.

1 Claim.

The present invention is concerned with compositions of the type that function by the release of nascent oxygen under body heat .for sustained therapeutic action.

As conducive to a clear understanding of the invention, it is noted that while the maximum available oxygen content of ozonized olive oillor practical purposes, is but 1.3 per cent, yet it is not feasible to use that composition full strength on delicate tissues. Such composition will cause a severe and painful stinging sensation when applied to the nasal passages for instance,

unless the oxygen content is maintained at or below .5 per cent, 1. e., not more than one-third full strength. Moreover, the completely ozonized olive oil has objectionable'odors that are not easy to mask, and the attempt to mask the s to other difficulties. v

Such ozonized oilis furthermore relatively immiscible with other oils such as unozonized olive oil or mineral oil, so that dilution of 'full strength ozonized oil gives rise to mechanical difficulties, aside from the reduced therapeutic eiiectiveness of the diluted product. eign material such as solubilizing agents, in an efiort to promote the mixture of the ozoniz-ed oil .with diluent is apt to lead to other complications,

n the. other hand, where it is attempted to ozonize the olive oil to a lesser degree, within the V limits that admit of painless application to delicate tissues the critical control of such limited e leads The introduction of forembodiment, substantially pure glycerinetrioleate is ozonized by any of the conventional ozonizing processes, desirably by s'lent electric discharge. The double bondofeach of the three acid radicals which esterify the glycerol is thus ozonized,

three oxygen atoms bridging between the carbon atoms that flankthe double bond on each of the three acid radicals.

The compound, when ozonized to the maximum extent practically attainable on a commercial scale, may. contain as high as 1.85 per cent of available oxygen thus added to the molecule of glycerol trioleate, and this is fully nity per cent higher than the corresponding maximum 1. e. '1. per cent of oxygen capable of being combined with olive oil. I The efiectiveness of the composition is thus considerably greater than that of ozonized olive oil,

. as those of the nasal passages even when used sues to which it is applied, without r .addition of oxygen to the molecule-is dimcult and the stability of the product on storage is relatively low.

It is among the objects of the present invention to provide a composition with an oxygen content capable of being slowly released in nascent vform under body heat, which oxygen content shall be much higher than the maximum attainable with olive oil, and which-composition shall yet be non-irritating in its full concentration.

even'when applied to the most'delicate tissues of the human body such, for instance, as the nasal passages.

Another object is to provide a composition for the above purpose,.which is suiilciently viscous to stay in place for effective action on the organ or upon the-tissue to. which it is applied, which has no objectionableodor, and which; while it efiectively releasesnascent oxygen when applied to body tissues, will retain its effectiveness ror' all practical purposes, when sealed'in a jar or flask in storage at normal "room temperature for a period as much astwo years.

0 the ozonized glycerol trioleate even with its high apart from the vitally important. circumstance that it is non-irritating to delicate tissues such By reason of its high added oxygen ingly 'ozonized olive'oil, sothat it will more reliably' remain in situ on the organ or on the tiseadily flowing therefrom and will function for hours by the a slow release of therapeutic nascent oxygen given up bythe molecule under body heat. The composition has no objectionable odor and need therefore not be masked and the mechanical diflicul'ty of admixing essential oils therewith and the dilution-and other objections incurred by such masking are obviated.

Except for the desiredrelease of nascent oxygen there is no break-down of the molecular structure of the composition during use. No foreign matter such as ketones, aldehydes or thelike, even small proportions of which would be irritating is present or is formedin the course of theuse of thecomposition.

While the pr ce 0! such stable saturated oils in the composition as may be-miscible with the ozonized glycerlne trioleate would theoretionly do no particular harm hysiologically, lution would be incurred, .so that the available nascent oxygen is of-lowe ercentage andthe composition is accordingly less eflective, without advantages, since as above noted,

' av ble nascent oxygen content is non-irritating to delicate tissu s The relatively viscous composition constituting According to theinventiomin one. practical the medicament or the present invention will not deteriorate materially when stored in flas or jars at norma1 room temperatures.

The composition is germicidal, fungicidal and nasal and vaginal tracts, the sinuses and the like. The composition produces exceptionally meritorious results in the treatment of secondary or tertiary burns. Another application is as a vermifuge. The composition may be solidified suftory purposes, by admixing the samewith hydrogenated cotton seed oil or the like.

Esters of fatty acids with two double bonds,

tionable from this standpoint. The ozonization of oils that contain such ingredients even in small proportions, especially if they also contain oxidizable coloring and flavoring matter is not some of them tend to explode on ozonizing.

As many changes could be made in the above out. polymerization, oxidation or decomposition.

CHARLES C. JOHNSON.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4451480 *Apr 16, 1982May 29, 1984James Howard BrownMethod of treating acne using ozonized materials
US4591602 *Apr 18, 1984May 27, 1986James H. BrownOzonide esters and topical compositions containing same
US4983637 *Jun 8, 1989Jan 8, 1991Stephen HermanMethod for treating viral infection of HIV
US5086076 *Oct 19, 1990Feb 4, 1992Stephen HermanAntiviral pharmaceutical compositions comprising a terpene ozonide
US5093326 *Jun 19, 1989Mar 3, 1992Stephen HermanRepellant compositions
US5126376 *Oct 19, 1990Jun 30, 1992Stephen HermanMethod for treating viral infection using topical administration
US5190977 *Nov 21, 1991Mar 2, 1993Stephen HermanAntiviral compositions
US5190979 *Jun 9, 1992Mar 2, 1993Stephen HermanOzonides of terpenes and their medical uses
US5260342 *Jun 18, 1992Nov 9, 1993Stephen HermanMethod for treating viral infection parenterally
US5270344 *Feb 24, 1992Dec 14, 1993Stephen HermanMethod of treating a systemic disorder using trioxolane and diperoxide compounds
US5364879 *Feb 14, 1994Nov 15, 1994Cliveden Ltd.Medical uses of trioxolane and diperoxide compounds
US5785988 *May 10, 1996Jul 28, 1998Fust; Charles A.Composition for freshening nostrils and sinus cavities
US6344210Feb 16, 2001Feb 5, 2002Charles A. FustComposition for freshening nostrils and sinus cavities
US20050084454 *Oct 13, 2004Apr 21, 2005Sinofresh Healthcare, Inc.Compositions and methods for cleaning nasal cavities
US20060019987 *Jul 22, 2005Jan 26, 2006Fust Charles AMethods and compositions for inhibiting, destroying, and/or inactivating viruses
US20100262098 *Dec 21, 2007Oct 14, 2010Sca Hygiene Products AbAbsorbent article with odour control substance
US20110150959 *Oct 3, 2008Jun 23, 2011Sca Hygiene Products AbWipe with odour control substance
EP2331149A1 *Oct 3, 2008Jun 15, 2011Sca Hygiene Products ABWipe with odour control substance
WO1989012626A1 *Jun 16, 1989Dec 28, 1989Stephen HermanOzonides of terpenes and their medical uses
WO1990014764A1 *Jun 5, 1990Dec 13, 1990Stephen HermanMethod for treating viral infection
WO1993012654A1 *Dec 17, 1992Jul 8, 1993Stephen HermanMedical uses of trioxolane and diperoxide compounds
WO2003085072A1 *Apr 2, 2003Oct 16, 2003Centro Nacional De Investigaciones Cientificas (Cnic)Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes
WO2009082287A1 *Dec 21, 2007Jul 2, 2009Sca Hgiene Products AbAbsorbent article with odour control substane
WO2012168770A1Nov 30, 2011Dec 13, 2012Universita' Del SalentoProcess for ozonization of a vegetable oil
Classifications
U.S. Classification554/213, 424/76.2, 549/431
International ClassificationA01N1/02
Cooperative ClassificationA01N1/02, A01N1/0205
European ClassificationA01N1/02, A01N1/02C